You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Hemophilia

Showing 1 - 25 of 949
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lower Extremity Muscles in Patients With Hemophilia

Not yet recruiting
  • Hemophilia
  • +2 more
    • Gaziantep, Şahinbey, Turkey
      Hasan Kalyoncu University
    Jul 31, 2023

    Liver Biopsy Following Gene Therapy For Hemophilia

    Not yet recruiting
    • Hemophilia A
    • Hemophilia B
    • Liver Biopsy
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    Jun 27, 2023

    Patterns of Hemophilia Care in Assiut Children Patients

    Not yet recruiting
    • Hemophilia A
    • Hemophilia B
      • (no location specified)
      Jul 29, 2023

      Characterize Effectiveness and Safety of HEMGENIX® in Hemophilia

      Not yet recruiting
      • Hemophilia B
      • HEMGENIX
      • Factor IX (FIX)
      • (no location specified)
      Aug 23, 2023

      Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

      Not yet recruiting
      • Hemophilia B Without Inhibitor
      • Low dose KL001
      • +2 more
      • (no location specified)
      Nov 5, 2023

      Hemophilia B Without Inhibitor Trial (Low dose KL001, Middle dose KL001, High dose KL001)

      Not yet recruiting
      • Hemophilia B Without Inhibitor
      • Low dose KL001
      • +2 more
      • (no location specified)
      Nov 5, 2023

      Vitamin K Antagonist Versus Direct Oral Anticoagulant Treatments

      Completed
      • Hemophilia A
      • +2 more
      • Vitamin K Antagonist - Drug
      • Brest, France
      • +5 more
      Apr 6, 2023

      Hemophilia A, Hemophilia B Trial in Istanbul (Closed Chain Exercise Group, Proprioceptive Exercise Group)

      Not yet recruiting
      • Hemophilia A
      • Hemophilia B
      • Closed Chain Exercise Group
      • Proprioceptive Exercise Group
      • Istanbul, Turkey
        İstanbul University-Cerrahpaşa
      May 18, 2023

      Male Hemophilia B Previously Treated With Etranacogene

      Not yet recruiting
      • Hemophilia B
      • AAV5-hFIXco-Padua
      • (no location specified)
      Jul 31, 2023

      Hemophilia A, Hemophilia B Trial (SerpinPC)

      Not yet recruiting
      • Hemophilia A
      • Hemophilia B
      • (no location specified)
      Mar 16, 2023

      Hemophilia B With Inhibitor, Hemophilia B Trial (SerpinPC)

      Not yet recruiting
      • Hemophilia B With Inhibitor
      • Hemophilia B
      • (no location specified)
      Mar 16, 2023

      Bleeding Rates Among Severe Hemophilia A on Emicizumab

      Not yet recruiting
      • Hemophilia A
      • Newark, New Jersey
        Newark Beth Israel Medical Center
      Oct 26, 2023

      Hemophilia B Trial (CSL222 (AAV5-hFIXco-Padua))

      Not yet recruiting
      • Hemophilia B
      • CSL222 (AAV5-hFIXco-Padua)
      • (no location specified)
      Aug 14, 2023

      Efanesoctocog Alfa on Long-term Joint Health in Hemophilia A

      Not yet recruiting
      • Hemophilia A
      • Efanesoctocog Alfa BIVV001
      • (no location specified)
      Jun 19, 2023

      Patients With End Stage Liver Disease

      Not yet recruiting
      • Liver Cirrhosis
      • +6 more
        • Palo Alto, California
          Stanford Hospital
        Aug 23, 2023

        A Prospective and Retrospective Interventional Study on

        Recruiting
        • Severe Hemophilia A Without Inhibitor
        • serum biomarker.
        • Taipei, Neihu Dist., Taiwan
          Tri-Service General Hospital Hemophilia Care Center
        Aug 10, 2023

        Hemophilia A Trial (NXT007)

        Not yet recruiting
        • Hemophilia A
        • (no location specified)
        Aug 4, 2023

        Severe Hemophilia A Without Inhibitor, Joint Bleed Trial in Bangkok ("Emicizumab", "HEMLIBRA®")

        Recruiting
        • Severe Hemophilia A Without Inhibitor
        • Joint Bleed
        • "Emicizumab", "HEMLIBRA®"
        • Bangkok, Thailand
          King Chulalongkorn Memorial hospital
        Nov 25, 2023

        Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)

        Not yet recruiting
        • Hemophilia A With Inhibitor
        • SCT800 and Daratumumab
        • (no location specified)
        May 24, 2023

        ATHN 8: Previously Untreated Patients (PUPs) Matter Study

        Completed
        • Hemophilia
        • +7 more
          • Phoenix, Arizona
          • +26 more
          Jan 30, 2023

          Hemophilia B Trial (BBM-H901)

          Not yet recruiting
          • Hemophilia B
          • (no location specified)
          Feb 6, 2023

          Hemophilia A Trial in Little Rock (ASC618)

          Recruiting
          • Hemophilia A
          • ASC618
          • Little Rock, Arkansas
            Arkansas Children's Hospital
          Jan 30, 2023

          Dynamics of Anti-factor VIII Antibody Signature During Treatment

          Not yet recruiting
          • Severe Hemophilia A
          • +2 more
          • no interventions
          • (no location specified)
          Apr 4, 2023

          Hemophilia A Trial in Tianjin (Single dose intravenous injection of BBM-H803)

          Recruiting
          • Hemophilia A
          • Single dose intravenous injection of BBM-H803
          • Tianjin, Tianjin, China
            Institute of Hematology & Blood Diseases Hospital Chinese Academ
          Oct 31, 2023

          Hemophilia B Trial in Beijing (Sodium valproate extended-release tablets)

          Recruiting
          • Hemophilia B
          • Sodium valproate extended-release tablets
          • Beijing, China
            PLA General Hospital
          Jun 17, 2023